Accueil
Envoyer à un ami
Imprimer
Grand
Petit
Partager
ACTUALITES

Novartis International AG - Novartis announces first CAR-T cell therapy BLA for pediatric and young adult patients with r/r B-cell ALL granted FDA Priority Review


- 29 Mars 2017 modifié le 1 Janvier 1970


Novartis International AG / Novartis announces first CAR-T cell therapy BLA for pediatric and young adult patients with r/r B-cell ALL granted FDA Priority Review . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely...

Source : https://www.romandie.com/news/Novartis-Internation...